Wishing you all the joys of the season! 
North America Eye Drops Market Forecast to 2030
North America Eye Drops Market Forecast to 2030 – Regional Analysis – by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application {Eye Diseases (Dry Eye, Glaucoma, Cataract, and Others), Eye Care, and Others}, and Purchase Mode (OTC and Prescription)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Prevalence of Ophthalmic Diseases Fuels North America Eye Drops Market
The incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye leading to vision impairment is rising among the population, especially in developed countries. A dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to a study, “National Health and Wellness Survey,” conducted in the US in April 2020, ~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence had surged by 2.7% among people aged 18−34 years. According to Novaliq GmbH, ~17 million Americans currently suffer from dry eye disease.
Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema may also become apparent. According to an article published by the American Academy of Ophthalmology, it is estimated that by 2030 an estimated 191 million people globally will suffer from diabetic retinopathy. According to Medscape, ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually.
According to an article published by the World Health Organization (WHO) in 2022, ~2.2 billion people worldwide suffer from near or distant vision impairment. The leading causes of vision impairment are cataracts (~94 million cases) and uncorrected refractive errors (~88.4 million cases). Doctors generally prescribe eye drops for the treatment and prevention of ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases is fueling the growth of the North America eye drops market .
North America Eye Drops Market Overview
The North America eye drops market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising awareness of dry eye conditions, an increase in the aging population, and technological advancements in eye treatment procedures with the rising incidence of eye disorders. Dry eye disease is a common but underdiagnosed condition in the US. The growing geriatric population further triggers the prevalence of dry eye disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as macular degeneration, cataract, diabetic retinopathy, and glaucoma are the leading causes of blindness and low vision in the US. Other common eye disorders reported in the country include amblyopia and strabismus. With aging populations and the increased frequency of younger adults receiving refractive surgeries, dry eye is expected to affect as many as 2.79 million men in the US by 2030.
The US is the largest and fastest-growing country in the North America eye drops market. The market in this country is ascribed to the increasing incidence of dry eye disease among people. Various companies offering different eye drops and lenses to treat dry eye condition have presence in the US. Also, the rising healthcare expenditure favors the growth of the North America eye drops market in the US.
North America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)
North America Eye Drops Market Segmentation
The North America eye drops market is segmented into type, application, purchase mode, and country.
Based on type, the North America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the North America eye drops market in 2022.
Based on application, the North America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the North America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the North America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the North America eye drops market in 2022.
Based on country, the North America eye drops market is segmented into the US, Canada, and Mexico. The US dominated the North America eye drops market in 2022.
AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, and Similasan Corp are some of the leading companies operating in the North America eye drops market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Research, the North America eye drops market was valued at US$ 8,030.88 million in 2022 and is expected to reach US$ 12,289.12 million by 2030, registering a CAGR of 5.5% from 2022 to 2030. Rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the critical factors attributed to the North America eye drops market expansion.
Eye diseases hold a substantial share in lifestyle diseases due to the increased use of smartphones, laptops, and computers. The modern lifestyle, which involves increased screen time, is responsible for triggering eye-related problems. Eye health is significantly compromised in this technological era. Working on computers for a long time eventually affects the health of the eyes. Individuals with chronic eye problems and refractive errors are at higher risk of developing digital eye strain (DES).
Extreme exposure to blue rays emitting from smartphones, tablets, iPads, and laptops also causes serious eye damage. Due to the COVID-19 outbreak, all companies opted for work-from-home (WFH) to prevent the spread of COVID-19. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by Frontiers, the repeated use of digital devices for more than two continuous hours is putting the user at a great risk of developing DES due to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. This flexibility with regard to work location has led to an increase in screen time. Such lifestyle changes will eventually damage eye health, generating a greater demand for eye drops.
On the contrary, product recalls hamper the North America eye drops market.
Based on type, the North America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held 38.1% share of North America eye drops market in 2022, amassing US$ 3,061.87 million. It is projected to garner US$ 4,772.82 million by 2030 to expand at 5.7% CAGR during 2022–2030.
Based on application, the North America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held 65.2% share of North America eye drops market in 2022, amassing US$ 5,238.26 million. It is projected to garner US$ 7,940.97 million by 2030 to expand at 5.3% CAGR during 2022–2030. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.
Based on purchase mode, the North America eye drops market is segmented into OTC and prescription. The prescription segment held 69.5% share of North America eye drops market in 2022, amassing US$ 5,583.97 million. It is projected to garner US$ 8,715.00 million by 2030 to expand at 5.7% CAGR during 2022–2030.
Based on country, the North America eye drops market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 78.1% share of North America Eye Drops Market in 2022. It was assessed at US$ 6,270.51 million in 2022 and is likely to hit US$ 9,761.24 million by 2030, exhibiting a CAGR of 5.7% during 2022–2030.
Key players operating in the North America eye drops market are AbbVie Inc, Akorn Operating Company LLC, Alcon AG,
Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, and Similasan Corp, among others.
In June 2023, Bausch + Lomb Corporation launched Biotrue Hydration Boost Contact Lens Rehydrating drops in US, the first and only preservative-free rehydrating drop in a multi-dose bottle that is indicated to lubricate and rewet soft contact lenses, including daily disposables, and rigid gas permeables.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Eye Drops Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Pipeline Analysis
4.4 Purchase Mode
5. North America Eye Drops Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Ophthalmic Diseases
5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
5.4.1 Changing Lifestyle
5.5 Impact Analysis
6. Eye Drops Market – North America Market Analysis
6.1 North America Eye Drops Market Revenue (US$ Mn), 2022 – 2030
7. North America Eye Drops Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
7.4.1 Overview
7.4.2 Artificial Tears: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
7.5.1 Overview
7.5.2 Hormones: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Eye Drops Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
8.3.1 Overview
8.3.2 Eye Diseases: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Dry Eye
8.3.2.1.1 Overview
8.3.2.2 Dry Eye: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Glaucoma
8.3.2.3.1 Overview
8.3.2.3.2 Glaucoma: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Cataract
8.3.2.4.1 Overview
8.3.2.4.2 Cataract: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
8.4.1 Overview
8.4.2 Eye Care: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Eye Drops Market – Revenue and Forecast to 2030 – by Purchase Mode
9.1 Overview
9.2 North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
9.3.1 Overview
9.3.2 Prescription: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
9.4.1 Overview
9.4.2 OTC: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Eye Drops Market – Revenue and Forecast to 2030 – Country Analysis
10.1 North America Eye Drops Market
10.1.1 Overview
10.1.1.1 US: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 US: North America Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.1.4 US: North America Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.1.4.1 US: North America Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.1.1.5 US: North America Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.1.2 Canada: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: North America Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.2.4 Canada: North America Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.2.4.1 Canada: North America Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.1.2.5 Canada: North America Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
10.1.1.3 Mexico: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: North America Eye Drops Market, by Type, 2020–2030 (US$ Million)
10.1.1.3.4 Mexico: North America Eye Drops Market, by Application, 2020–2030 (US$ Million)
10.1.1.3.4.1 Mexico: North America Eye Drops Market, For Eye Diseases by Application, 2020–2030 (US$ Million)
10.1.1.3.5 Mexico: North America Eye Drops Market, by Purchase Mode, 2020–2030 (US$ Million)
11. North America Eye Drops Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Akorn Operating Company LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Alcon AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Pfizer Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Prestige Consumer Healthcare Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Similasan Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AbbVie Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bausch & Lomb Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1.            North America Eye Drops Market Segmentation
Table 2.            US: North America Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3.            US: North America Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4.            US: North America Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5.            US: North America Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 6.            Canada: North America Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 7.            Canada: North America Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 8.            Canada: North America Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9.            Canada: North America Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 10.         Mexico: North America Eye Drops Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 11.         Mexico: North America Eye Drops Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12.         Mexico: North America Eye Drops Market, For Eye Diseases by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13.         Mexico: North America Eye Drops Market, by Purchase Mode – Revenue and Forecast to 2030 (US$ Million)
Table 14.         Organic Developments in the Eye Drops Market
Table 15.         Inorganic Developments in the Eye Drops Market
Table 16.         Glossary of Terms, North America Eye Drops Market
Â
Â
LIST OF FIGURES
Figure 1.          North America Eye Drops Market Segmentation, By Country
Figure 2.          North America – PEST Analysis
Figure 3.          Pipeline Analysis
Figure 4.          North America Eye Drops Market: Key Industry Dynamics
Figure 5.          North America Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6.          North America Eye Drops Market Revenue (US$ Mn), 2020 – 2030
Figure 7.          North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8.          Antibiotics: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9.          Artificial Tears: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10.       Hormones: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11.       Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12.       North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13.       Eye Diseases: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14.       Dry Eye: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15.       Glaucoma: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16.       Cataract: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17.       Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18.       Eye Care: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19.       Others: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.       North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21.       Prescription: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22.       OTC: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.       North America Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24.       North America Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25.       US: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26.       Canada: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27.       Mexico: North America Eye Drops Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28.       Growth Strategies in the Eye Drops Market (%)
List of Companies
o AbbVie Inc                                                             Â
o Akorn Operating Company LLCÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
o Alcon AGÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
o Bausch & Lomb Inc                                              Â
o Pfizer Inc                                                               Â
o Prestige Consumer Healthcare Inc.                  Â
o Rohto Pharmaceutical Co Ltd                            Â
o Similasan Corp                                                      Â
You must be logged in to post a review.
Reviews
There are no reviews yet.